This study shows a reduction in serum a syn levels in RLS patients and suggests that it may be the reason for reduced dopamine/faulty dopamine system in RLS patients.
It also mentions that a high percentage are experiencing augmentation.
What a surprise!
Written by
Joolsg
To view profiles and participate in discussions please or .
And still nearly every UK neurologist is dishing out dopamine agonists and trying to convince patients that augmentation is unlikely to happen. It really defies rational belief.
Interesting. The link only gives access to the summary (?). I’ll try to get the full paper later, as I am curious about why they looked at alpha-synuclein and what its usual function is. It would be interesting if it could be used as a biomarker, but as that isn’t mentioned in the summary, I guess not.
Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.
Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.